Medtronic, US multinational leader in medical technologies, invested heavily in two companies of its group that are part of the regional biomedical district of Mirandola (Modena): Bellco and Mallinckrodt.
Indeed, Bellco invested about 54 million euros from 2017 to 2021, increasing employment from 400 to 560 units. The Regional Government supported this growth financing an innovative investment project proposed by Bellco in 2019, hiring 20 new employees. The incentive was part of the regional Agreement for the Settlement and Development of Enterprises, policy instrument provided by the Regional Law 14/2014 for the Promotion of Investments. Mallinckrodt has also increased its number of regional employees by more than double in the past three years.
These data show the strategic role of the district of Mirandola for the multinational, with the production of disposable devices and accessories for intensive care, filters and circuits for transporting oxygen, machinery and filters for dialysis and kidney function support. Medtronic also supported the companies of the regional district through a collaboration with the Technopole of Mirandola, Maverx Foundation and the Universities.
